Clinicopathology of recurrent hepatocellular carcinomas after radiofrequency ablation treated with salvage surgery (Q44379007)

2 December 2017

title

Clinicopathology of recurrent hepatocellular carcinomas after radiofrequency ablation treated with salvage surgery (English)

1 reference

2 December 2017

Naoki Yamamoto

1

1 reference

2 December 2017

Keiichi Okano

2

1 reference

2 December 2017

Yoshio Kushida

3

1 reference

2 December 2017

Akihiro Deguchi

4

1 reference

2 December 2017

Shinichi Yachida

5

1 reference

2 December 2017

Yasuyuki Suzuki

6

1 reference

2 December 2017

publication date

18 September 2013

1 reference

2 December 2017

1 reference

2 December 2017

volume

44

1 reference

2 December 2017

issue

11

1 reference

2 December 2017

page(s)

1062-1071

1 reference

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12223

Prediction of posthepatectomy hepatic functional reserve by serum hyaluronate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12223

Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12223

Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12223

Mortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma: a national survey of 54,145 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12223

Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12223

Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12223

Factors for early tumor recurrence of single small hepatocellular carcinoma after percutaneous radiofrequency ablation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12223

Radiofrequency ablation of hepatocellular carcinoma: Current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12223

Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12223

Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12223

A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12223

Comparative assessment of the safety and effectiveness of radiofrequency ablation among elderly medicare beneficiaries with hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12223

Management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12223

p27(Kip1)is overexpressed in very early stages of hepatocarcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12223

Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12223

Jun activation domain binding protein 1 is overexpressed from the very early stages of hepatocarcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12223

Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12223

Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12223

Management of hepatocellular carcinoma: An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12223

Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12223

A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12223

A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12223

Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12223

Insufficient radiofrequency ablation promotes angiogenesis of residual hepatocellular carcinoma via HIF-1α/VEGFA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12223

Long-term outcomes of repeat hepatic resection in patients with recurrent hepatocellular carcinoma and analysis of recurrent types and their prognosis: a single-center experience in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12223

Review: assessment of cell proliferation in histological material

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12223

Histopathology of the tissue adhering to the multiple tine expandable electrodes used for radiofrequency ablation of hepatocellular carcinoma predicts local recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12223

A morpho-molecular prognostic model for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12223

The murine gene p27Kip1 is haplo-insufficient for tumour suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12223

Salvage hepatectomy for local recurrent hepatocellular carcinoma after ablation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12223

Survival analysis of re-resection versus radiofrequency ablation for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12223

Distant metastasis occurs late during the genetic evolution of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12223

Peritoneal seeding of hepatocellular carcinoma: clinicopathological characteristics of 17 autopsy cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12223

21 January 2018

Identifiers

DOI

10.1111/HEPR.12223

1 reference

2 December 2017

1 reference